FDA delays Gardasil for older women

The FDA has decided to wait for more data from Merck before making a decision on whether or not to expand the indication of the HPV vaccine Gardasil for use in women ages 27 through 45, Merck announced today. Report

Suggested Articles

Compared with the FDA "boxed warning," the EMA version puts a smaller restriction on the higher dose but broadens the cautionary language.

Shionogi's newest antibiotic Fetroja has now earned the FDA's approval, but will a mortality-rate warning scuttle the drug's chances?

Novartis' Sandoz doubled down in Japan as Lupin retreated. Dr. Reddy's posted a loss tied to its Zantac recall. Aslan's varlitinib failed again.